Tag Archives: LUB

Hot Medical Stocks To Own Right Now

Several days ago Fitbit (FIT) and Dexcom (DXCM) announced they are partnering to develop CGM (continuous glucose monitoring) solutions for people living with diabetes. The first product will incorporate DXCM’s CGM data and bridge it with FIT’s new Ionic watch. Users of Android and iOS devices would be able to see “activity and glucose levels, right on their wrist.”

So what’s the big deal?

Th truth is that it isn’t such a big deal for DXCM. The company already sells and markets a similar product for both Android and iOS devices.

However, please note that the Ionic will have four days of battery life, which could be considered mission critical in such medical applications. Apple’s (AAPL) new iWatch 3 on the other hand clams to have up to 18 hours of battery life.

Also, the Ionic smartwatch has a built-in GPS tracker, an optical heart rate sensor, an accelerometer and a blood oxygen sensor. So perhaps DXCM and FIT might have more plans for medical Apps in the future. The AAPL iWatch does not have all those amenities, and to get the GPS tracker you have to fork out about $30 more.

Hot Medical Stocks To Own Right Now: Globalstar Inc.(GSAT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday morning, the telecommunication services shares rose 1.06 percent. Meanwhile, top gainers in the sector included Globalstar, Inc. (NYSE: GSAT), up 5 percent, and Partner Communications Company Ltd. (NASDAQ: PTNR) up 4 percent.

  • [By Max Byerly]

    Globalstar (NYSEAMERICAN:GSAT) saw a significant growth in short interest in April. As of April 13th, there was short interest totalling 86,799,863 shares, a growth of 6.9% from the March 30th total of 81,207,186 shares. Based on an average daily volume of 6,541,037 shares, the short-interest ratio is currently 13.3 days. Approximately 14.4% of the shares of the stock are short sold.

  • [By Anders Bylund]

    Shares of Globalstar Inc. (NYSEMKT:GSAT) went on a roller coaster ride this morning. The satellite communications specialist’s stock bottomed out in a 16% drop just after 10 a.m. EDT, recovering to a less dramatic 7% decline an hour later. The company is the target of a complicated merger deal today, and investors on the open market are not loving the idea.

  • [By Paul Ausick]

    Globalstar Inc. (NYSEAMERICAN: GSAT) traded down about 5.9% Monday and posted a new 52-week low of $0.48 after closing Friday at $0.51. The stock’s 52-week high is $2.30. Volume totaled about 4.4 million, about 20% below the daily average of around 5.4 million. The company had no specific news.

  • [By Paul Ausick]

    Globalstar Inc. (NYSEAMERICAN: GSAT) traded down about 2% Friday and posted a new 52-week low of $0.49 after closing Thursday at $0.50. The stock’s 52-week high is $2.30. Volume totaled about 4.2 million, almost 20% below the daily average of around 5.4 million. The company had no specific news.

Hot Medical Stocks To Own Right Now: Emerson Electric Company(EMR)

Advisors’ Opinion:

  • [By Max Byerly]

    Flippin Bruce & Porter Inc. decreased its holdings in Emerson Electric (NYSE:EMR) by 33.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 66,251 shares of the industrial products company’s stock after selling 33,574 shares during the quarter. Flippin Bruce & Porter Inc.’s holdings in Emerson Electric were worth $4,525,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Shane Hupp]

    Element Capital Management LLC acquired a new stake in Emerson Electric Co. (NYSE:EMR) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 202,986 shares of the industrial products company’s stock, valued at approximately $13,864,000.

  • [By Logan Wallace]

    D.A. Davidson & CO. lifted its position in shares of Emerson Electric (NYSE:EMR) by 1.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 574,584 shares of the industrial products company’s stock after buying an additional 7,640 shares during the period. Emerson Electric makes up about 0.8% of D.A. Davidson & CO.’s holdings, making the stock its 25th biggest holding. D.A. Davidson & CO.’s holdings in Emerson Electric were worth $39,244,000 at the end of the most recent reporting period.

Hot Medical Stocks To Own Right Now: Luby's, Inc.(LUB)

Advisors’ Opinion:

  • [By Max Byerly]

    Headlines about Luby’s (NYSE:LUB) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Luby’s earned a news impact score of 0.10 on Accern’s scale. Accern also gave news coverage about the restaurant operator an impact score of 47.2262144037183 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Joseph Griffin]

    Main Street Capital (NYSE: MAIN) and Luby’s (NYSE:LUB) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation and risk.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
    Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
    Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
    Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
    Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
    Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
    Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
    Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
    Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
    Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent

Hot Medical Stocks To Own Right Now: HSBC Holdings PLC (HSBA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    HSBC (LON:HSBA) had its target price lowered by equities research analysts at Shore Capital from GBX 721 ($9.60) to GBX 625 ($8.32) in a report issued on Tuesday. The brokerage presently has a “sell” rating on the financial services provider’s stock. Shore Capital’s price objective indicates a potential downside of 14.71% from the company’s previous close.

  • [By Ethan Ryder]

    HSBC (LON:HSBA) had its price target dropped by equities research analysts at Citigroup from GBX 810 ($10.78) to GBX 800 ($10.65) in a report released on Tuesday. The brokerage currently has a “buy” rating on the financial services provider’s stock. Citigroup’s price target points to a potential upside of 9.59% from the stock’s previous close.

Top 5 Heal Care Stocks To Own Right Now

Hybrid cloud data services provider NetApp Inc. (NASDAQ:NTAP) hosted its annual Analyst Day on April 5. The company raised its short- and long-term growth outlooks. They also added firepower to the capital returns program, adding $4 billion to the share buyback program and promising to double the dividend.

Investors and analysts alike applauded. Analysts upgraded NetApp stock. Investors bought NetApp stock.

Now, NTAP stock trades trades right around all-time highs despite the S&P 500 being 8% off recent highs.

Can this rally in NetApp stock continue?

I think so. NTAP is fundamentally transforming its business model to be not only relevant, but necessary, in today’s data-driven digital world. Growth prospects are consequently improving. Meanwhile, the stock remains cheap.

Overall, I think NetApp stock can rally to and above the $75 mark over the next several months. Here’s a deeper look.

Big Growth Narrative in Data

NTAP has successfully pivoted its business model from low-growth to improving-growth by focusing on providing solutions for companies immersed in secular data-driven digital transformations.

Top 5 Heal Care Stocks To Own Right Now: MarineMax, Inc.(HZO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on MarineMax (HZO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    MarineMax (NYSE: HZO) and Advance Auto Parts (NYSE:AAP) are both retail/wholesale companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership and valuation.

  • [By Lisa Levin]

    MarineMax, Inc. (NYSE: HZO) shares were also up, gaining 24 percent to $21.70 as the company posted upbeat Q2 results and raised its FY18 outlook.

    Equities Trading DOWN

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,
  • [By Lisa Levin]

    MarineMax, Inc. (NYSE: HZO) shares were also up, gaining 24 percent to $21.80 as the company posted upbeat Q2 results and raised its FY18 outlook.

    Equities Trading DOWN

  • [By Lisa Levin] Gainers
    Comstock Resources, Inc. (NYSE: CRK) shares shot up 52 percent to $7.235 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    MarineMax, Inc. (NYSE: HZO) shares gained 24.2 percent to $21.80 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Mattersight Corporation (NASDAQ: MATR) shares rose 22 percent to $2.625 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) jumped 21.3 percent to $411.871 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 17 percent to $3.10 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) rose 15.9 percent to $18.34 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) gained 15.6 percent to $12.20 following Q1 results.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) surged 14.4 percent to $260.3901 following upbeat Q1 profit.
    Concord Medical Services Holdings Limited (NYSE: CCM) gained 13.8 percent to $3.70.
    Penn National Gaming, Inc. (NASDAQ: PENN) rose 13.5 percent to $29.815 after reporting strong Q1 results.
    BioTelemetry, Inc. (NASDAQ: BEAT) rose 13.5 percent to $38.30 as the company reported stronger-than-expected earnings for its first quarter.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 13.1 percent to $10.985 as the company reported upbeat results for its first quarter.
    SJW Group (NYSE: SJW) shares gained 11.8 percent to $63.59 following Q1 results. California Water Service Group made an offer for SJW.
    Churchill Downs Incorporated (NASDAQ: CHDN) climbed 9.8 percent to $278.40 following Q1 results.
    CYS Investments, Inc. (NYSE: CYS)

Top 5 Heal Care Stocks To Own Right Now: Blackstone GSO Senior Floating Rate Term Fund(BSL)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News articles about Blackstone/GSO Senior Fltg Rt Term Fund (NYSE:BSL) have trended somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Blackstone/GSO Senior Fltg Rt Term Fund earned a daily sentiment score of 0.19 on Accern’s scale. Accern also gave news coverage about the company an impact score of 47.9711105753708 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Ethan Ryder]

    Media headlines about Blackstone/GSO Senior Fltg Rt Term Fund (NYSE:BSL) have been trending somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Blackstone/GSO Senior Fltg Rt Term Fund earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave media coverage about the company an impact score of 47.1154940270027 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Top 5 Heal Care Stocks To Own Right Now: MutualFirst Financial Inc.(MFSF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on MutualFirst Financial (MFSF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Own Right Now: Luby's, Inc.(LUB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
    Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
    Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
    Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
    Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
    Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
    Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
    Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
    Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
    Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent

  • [By Joseph Griffin]

    Main Street Capital (NYSE: MAIN) and Luby’s (NYSE:LUB) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation and risk.

  • [By Max Byerly]

    Headlines about Luby’s (NYSE:LUB) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Luby’s earned a news impact score of 0.10 on Accern’s scale. Accern also gave news coverage about the restaurant operator an impact score of 47.2262144037183 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 5 Heal Care Stocks To Own Right Now: Grupo Aval Acciones y Valores S.A.(AVAL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Grupo Aval Acciones y Valores (AVAL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    ING Groep (NYSE: ING) and GRUPO AVAL ACCI/S (NYSE:AVAL) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

Best Medical Stocks To Own Right Now

The stock market sank slightly on Friday, with all three major market benchmarks giving up a small amount of ground from Thursday’s close. Slow GDP growth got the bulk of the blame from Wall Street, but it’s also common for market participants to take some money off the table going into the weekend after a strong week.

Meanwhile, earnings season continued to play out, and although the technology industry saw some extremely encouraging reports, not all stocks participated in the rally. Athenahealth (NASDAQ:ATHN), Synchrony Financial (NYSE:SYF), and Time (NYSE:TIME) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

Athenahealth gets a little sick

Shares of Athenahealth plunged 20% after the company reported discouraging results in its first-quarter financial report. The provider of cloud-based medical records said that sales were up 11% from the year-ago quarter, but the company posted a net loss, and even after adjusting for extraordinary items, Athenahealth saw its bottom line give up ground from the first quarter of 2016. Yet even though management remains optimistic about long-term business prospects for the company, CFO Karl Stubelis noted that sales were below expectations, and Athenahealth chose to revise its full-year outlook for both revenue and earnings downward. With investors having gotten used to lightning-fast growth from the medical records provider, Athenahealth will have to find ways to speed back up if it wants to satisfy its shareholders going forward.

Best Medical Stocks To Own Right Now: Attunity Ltd.(ATTU)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Attunity (ATTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Medical Stocks To Own Right Now: Hot Tech Stocks To Own For 20()

Advisors’ Opinion:

  • [By Max Byerly]

    (CURRENCY:) traded flat against the US dollar during the 24 hour period ending at 8:00 AM E.T. on April 18th. In the last seven days, has traded flat against the US dollar. One coin can currently be purchased for about $0.0000 or 0.00000000 BTC on exchanges including 295

  • [By Stephan Byrd]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get CBRE Group alerts:

    Parmer Innovation Center to become mammoth employment hub in Northeast Austin (bizjournals.com) Rockefeller leases 138,000 s/f to Blank Rome (rew-online.com) CBRE Group CEO expects another year of double-digit earnings growth (smartbrief.com) Contrasting CBRE Group (CBRE) and Colliers International Gr (CIGI) (americanbankingnews.com) Scanning the CBRE Group, Inc. (:CBRE) Charts What’s Next For the Shares? (derbynewsjournal.com)

    CBRE Group remained flat at $$47.42 during trading on Thursday, according to Marketbeat Ratings. The company’s stock had a trading volume of 1,305,500 shares, compared to its average volume of 2,132,441. The company has a market cap of $15.94 billion, a PE ratio of 17.50, a price-to-earnings-growth ratio of 1.16 and a beta of 1.70. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.18 and a quick ratio of 1.18. CBRE Group has a 12-month low of $46.79 and a 12-month high of $47.41.

  • [By ]

    For example, say Remind my wife about the party and say don’t forget to pick up a bottle of red wine tonight. Siri will know who your spouse is (or will ask you once) and place that in the To: field, and because you said about the party, Siri knows you want that in the Subject (Re:) field. You also said and say, which places words you said after that into the body of the email. This will all save you time!

Best Medical Stocks To Own Right Now: Luby's, Inc.(LUB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
    Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
    Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
    Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
    Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
    Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
    Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
    Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
    Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
    Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent

  • [By Max Byerly]

    Headlines about Luby’s (NYSE:LUB) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Luby’s earned a news impact score of 0.10 on Accern’s scale. Accern also gave news coverage about the restaurant operator an impact score of 47.2262144037183 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Best Medical Stocks To Own Right Now: STAAR Surgical Company(STAA)

Advisors’ Opinion:

  • [By Lisa Levin]

    STAAR Surgical Company (NASDAQ: STAA) shares shot up 26 percent to $21.03 after reporting upbeat Q1 results.

    Shares of Integrated Media Technology Limited (NASDAQ: IMTE) got a boost, shooting up 56 percent to $34.2425. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.

  • [By Joseph Griffin]

    STAAR Surgical (NASDAQ:STAA) was upgraded by equities researchers at TheStreet from a “c” rating to a “b-” rating in a research report issued on Monday.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca
  • [By Lisa Levin]

    STAAR Surgical Company (NASDAQ: STAA) shares shot up 28 percent to $21.40 after reporting upbeat Q1 results.

    Shares of Integrated Media Technology Limited (NASDAQ: IMTE) got a boost, shooting up 57 percent to $34.52. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 73.3 percent to $3.90.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares gained 51 percent to $33.1365. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Monaker Group, Inc. (NASDAQ: MKGI) shares jumped 34 percent to $3.00.
    Sharing Economy International Inc. (NASDAQ: SEII) shares rose 28.2 percent to $4.51 after gaining 9.32 percent on Wednesday.
    STAAR Surgical Company (NASDAQ: STAA) shares jumped 27.8 percent to $21.40 after reporting upbeat Q1 results.
    Boxlight Corporation (NASDAQ: BOXL) rose 20.5 percent to $8.920 after climbing 107.87 percent on Wednesday.
    Xspand Products Lab Inc (NASDAQ: XSPL) gained 19.5 percent to $ 5.97. Xspand Products priced its IPO at $5 per share.
    YRC Worldwide Inc. (NASDAQ: YRCW) rose 18.9 percent to $10.035 following upbeat quarterly earnings.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 18.3 percent to $3.0177. ENDRA Life Sciences is expected to report Q1 results on May 15.
    MYR Group Inc. (NASDAQ: MYRG) rose 18.1 percent to $35.85 after the company posted strong Q1 earnings.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares jumped 16 percent to $30.75 following upbeat quarterly earnings.
    TTM Technologies, Inc. (NASDAQ: TTMI) gained 13.7 percent to $16.53 after reporting Q1 results.
    Insight Enterprises, Inc. (NASDAQ: NSIT) shares surged 12 percent to $40.06 following better-than-expected Q1 earnings.
    TreeHouse Foods, Inc. (NYSE: THS) rose 11.8 percent to $40.93 following Q1 results.
    Engility Holdings, Inc. (NYSE: EGL) surged 11.2 percent to $27.36. Engility reported upbeat quarterly earnings.
    Synalloy Corporation (NASDAQ: SYNL) rose 10.7 percent to $19.10 following Q1 results.
    Logitech International S.A. (NASDAQ: LOGI)

Best Medical Stocks To Own Right Now: Waste Management, Inc.(WM)

Advisors’ Opinion:

  • [By ]

    For his “Executive Decision” segment, Cramer spoke with Jim Fish, president and CEO of Waste Management (WM) , which just posted an eight-cents-a-share earnings beat, but saw shares decline as investors worry over the impact of trade wars with China on the company’s recycling business.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Waste Management (WM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    KAMES CAPITAL plc grew its stake in shares of Waste Management (NYSE:WM) by 26.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 25,022 shares of the business services provider’s stock after buying an additional 5,215 shares during the period. KAMES CAPITAL plc’s holdings in Waste Management were worth $2,105,000 as of its most recent filing with the Securities and Exchange Commission.

Best Medical Stocks To Own Right Now: Accenture plc.(ACN)

Advisors’ Opinion:

  • [By ]

    But the segment revenue figures make it clear that momentum in areas such as cloud apps/services and security is being offset by pressures within older, non-cloud, software and services businesses in fields such as databases, operating systems, consulting, tech support and business process outsourcing (BPO). And that when one combines the good and the bad, the end-result is a company whose forex-adjusted growth remains noticeably below that of peers such as Microsoft (MSFT) , Accenture (ACN) , SAP (SAP) and Dell Technologies, and for which growing FCF remains a challenge.

  • [By Logan Wallace]

    Smith Asset Management Group LP lifted its position in shares of Accenture (NYSE:ACN) by 2.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 67,628 shares of the information technology services provider’s stock after acquiring an additional 1,398 shares during the quarter. Smith Asset Management Group LP’s holdings in Accenture were worth $10,381,000 at the end of the most recent quarter.

  • [By Steve Symington, Maxx Chatsko, and Brian Feroldi]

    To that end, we asked three top Motley Fool contributors to each pick a stock they think you would be wise to purchase and hold for the next 50 years. Read on to see why they like Corning (NYSE:GLW), Accenture (NYSE:ACN), and A.O. Smith (NYSE:AOS).

  • [By Wayne Duggan]

    From an investing standpoint, Foresi said IT Services stocks such as IBM (NYSE: IBM), Accenture Plc (NYSE: ACN) and Cognizant Technology Solutions Corp (NASDAQ: CTSH) could benefit from a rise in blockchain projects.

  • [By Max Byerly]

    Shares of Accenture Plc (NYSE:ACN) have been assigned a consensus recommendation of “Buy” from the twenty-seven ratings firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and fourteen have assigned a buy rating to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $160.70.

  • [By Money Morning News Team]

    The companies that participated in the demo included Cisco Systems Inc. (Nasdaq: CSCO), Microsoft Corp. (Nasdaq: MSFT), Accenture Plc. (NYSE: ACN), Fujitsu Ltd. (OTCMKTS: FJTSY), and Deutsche Telekom AG (OTCMKTS: DTEGY).

Best Biotech Stocks To Invest In Right Now

Media coverage about Biogen (NASDAQ:BIIB) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Biogen earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave news stories about the biotechnology company an impact score of 48.3115664476984 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Here are some of the news stories that may have effected Accern’s analysis:

Get Biogen alerts:

Biogen (BIIB) Expected to Post Quarterly Sales of $3.24 Billion (americanbankingnews.com) Biogen Inc (NASDAQ:BIIB): Does The Earnings Decline Make It An Underperformer? (finance.yahoo.com) 5 Trade Ideas For Monday: AMTD, BIIB, DEO, FITB, TECK (investing.com) $5.29 EPS Expected for Biogen (BIIB) This Quarter (americanbankingnews.com) Biogen (BIIB) Upgraded by ValuEngine to “Hold” (americanbankingnews.com)

Shares of Biogen traded up $5.45, reaching $281.51, during midday trading on Wednesday, according to MarketBeat Ratings. 1,514,169 shares of the company’s stock were exchanged, compared to its average volume of 1,729,786. Biogen has a 52-week low of $276.94 and a 52-week high of $281.57. The firm has a market cap of $59.58 billion, a price-to-earnings ratio of 12.91, a PEG ratio of 1.65 and a beta of 0.84. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.95 and a current ratio of 3.23.

Best Biotech Stocks To Invest In Right Now: Luby's, Inc.(LUB)

Advisors’ Opinion:

  • [By Max Byerly]

    Headlines about Luby’s (NYSE:LUB) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Luby’s earned a news impact score of 0.10 on Accern’s scale. Accern also gave news coverage about the restaurant operator an impact score of 47.2262144037183 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Prothena Corporation plc (NASDAQ: PRTA) shares dipped 69 percent to $11.48 after a disappointing update relating to the company's treatment for AL amyloidosis. Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan categories, said a Phase 2b study of its therapy called NEOD001 failed to achieve its primary or secondary endpoints. Prothena's Phase 2b study explored its NEOD001 therapy versus a placebo in previously-treated patients with AL amyloidosis and persistent cardiac dysfunction.
    Gridsum Holding Inc. (NASDAQ: GSUM) fell 44.3 percent to $4.06. Gridsum reported suspension of audit report on financial statements.
    Flotek Industries, Inc. (NYSE: FTK) shares declined 34.1 percent to $4.16 as the company issued weak revenue forecast for the first quarter.
    Akorn, Inc. (NASDAQ: AKRX) dropped 32.3 percent to $13.35 after Fresenius terminated its merger deal with Akorn.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 31.2 percent to $13.44. Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron.
    Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS) dropped 18 percent to $5.76. Controladora Vuela recently reported first-quarter results that showed a loss for the quarter. Imperial Capital downgraded Controladora Vuela Compania de Aviacion from Outperform to In-Line.
    Atossa Genetics Inc. (NASDAQ: ATOS) fell 18.2 percent to $2.8797 after declining 19.35 percent on Friday.
    Alcoa Corporation (NYSE: AA) fell 12.3 percent to $52.63.
    Luby's, Inc. (NYSE: LUB) shares declined 10.3 percent to $2.448 following Q2 results.
    Aceto Corporation (NASDAQ: ACET) shares tumbled 10 percent to $2.26.
    Pier 1 Imports, Inc. (NYSE: PIR) dipped 9.7 percent

Best Biotech Stocks To Invest In Right Now: Steelcase Inc.(SCS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    SpeedCash (CURRENCY:SCS) traded 13.6% lower against the dollar during the 1 day period ending at 10:00 AM ET on May 4th. One SpeedCash coin can now be purchased for approximately $2.71 or 0.00028080 BTC on major exchanges including YoBit, Cryptohub, Trade Satoshi and Crex24. During the last seven days, SpeedCash has traded 201.8% higher against the dollar. SpeedCash has a total market capitalization of $1.26 million and $26,755.00 worth of SpeedCash was traded on exchanges in the last 24 hours.

  • [By Max Byerly]

    SpeedCash (SCS) is a coin. SpeedCash’s total supply is 476,918 coins and its circulating supply is 467,791 coins. The Reddit community for SpeedCash is /r/SpeedCash and the currency’s Github account can be viewed here. SpeedCash’s official Twitter account is @SpeedCashMedia. SpeedCash’s official website is www.scash.ml.

  • [By Stephen Mack]

    Jim Hackett spent two decades as CEO of Michigan-based office furniture company Steelcase Inc. (NYSE: SCS). When he took over, the American workplace was shifting away from cubicles, and the company looked on the verge of extinction, with $70 million in annual losses.

  • [By Logan Wallace]

    Here are some of the media stories that may have impacted Accern’s rankings:

    Get Steelcase alerts:

    Vida Health Expands Platform to Tackle Comorbidities (prweb.com) Zacks: Brokerages Expect Steelcase (SCS) Will Announce Quarterly Sales of $756.45 Million (americanbankingnews.com) Knoll: Q1 Earnings Enough To Stay Long (seekingalpha.com) ValuEngine Downgrades Steelcase (SCS) to Sell (americanbankingnews.com) Should Stem Cells Spin SA.s (WSE:SCS) Recent Earnings Decline Worry You? (finance.yahoo.com)

    Several research analysts have weighed in on the company. ValuEngine lowered Steelcase from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Seaport Global Securities reaffirmed a “neutral” rating on shares of Steelcase in a research report on Monday, March 26th. Finally, Zacks Investment Research raised Steelcase from a “sell” rating to a “hold” rating in a research report on Wednesday, March 28th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $16.00.

Best Biotech Stocks To Invest In Right Now: Express-1 Expedited Solutions Inc.(XPO)

Advisors’ Opinion:

  • [By ]

    TheStreet’s founder and Action Alerts PLUS Portfolio Manager Jim Cramer analyzes Thursday’s trending stocks from the floor of the New York Stock Exchange including Macy’s (M) , Amazon (AMZN) , Etsy (ETSY) , XPO Logistics (XPO) and Groupon (GRPN) . 

  • [By Jeremy Bowman]

    Somebody’s got to deliver all of those products that we’re ordering online, and increasingly, that somebody isXPO Logistics(NYSE:XPO). The freight and logistics company has become the leader in last-mile delivery of heavy goods like furniture and appliances, making it a key partner of retailers like Amazon, IKEA,Wayfair, and Home Depot.

  • [By ]

    For his final “Executive Decision” segment, Cramer also checked in with Brad Jacobs, chairman and CEO of XPO Logistics (XPO) , the transportation provider with shares up 16% in 2018.

  • [By ]

    TheStreet’s founder and Action Alerts PLUS Portfolio Manager Jim Cramer said XPO Logistics (XPO) is a remarkable company.

    Cramer said UPS (UPS) has labor problems and people think FedEx (FDX) is expensive. “XPO has got a lot of things that they can do,” Cramer said. “They’re in M&A mode.”

  • [By ]

    XPO Logistics (XPO) : “This stock just won’t come down. “

    Over on Real Money, Cramer talks about how to trade the highly unlikely deal between Sprint (S) and T-Mobile (TMUS) . Get more of his insights with a free trial subscription to Real Money.

  • [By Rich Duprey, Nicholas Rossolillo, and Maxx Chatsko]

    Yet finding the best stocks to buy and hold isn’t easy. So to help get you started, we asked three Foolish investors to pick a growth stock that they believe investors would be wise to buy now and hold for the long term. Read on to learn why they like SunPower (NASDAQ:SPWR), salesforce.com (NYSE:CRM), and XPO Logistics (NYSE:XPO).

Top 10 Stocks To Watch For 2018

Your Pizza Hut delivery could one day arrive via a self-driving Toyota van.

Toyota unveiled a concept vehicle called e-Palette, which could host a mobile store, act as a ride-sharing service or deliver packages. The announcement was unveiled at International CES in Las Vegas on Monday.

The automaker said it is teaming up with a handful of partners, including Pizza Hut, Amazon, Chinese ridesharing giant Didi and Uber.

“Today, you have to travel to the stores,” Toyota president Akio Toyoda said at the event. “In the future with e-Pallete, the store will come to you.”

Although e-Palette is only a concept vehicle for now, he added that the company plans to pilot the technology at the 2020 Olympic Games in Tokyo. Tests in the U.S. and other areas are envisioned for the early 2020s.

Introducing the first Pizza Hut fully autonomous delivery concept vehicle. Excited for our future with @Toyota #CES2018 pic.twitter.com/YGNQUgijha

Top 10 Stocks To Watch For 2018: Valeant Pharmaceuticals International Inc(VRX)

Advisors’ Opinion:

  • [By Chris Lange]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) sawits shares hit a multiyear low this past week. There was hope for a turnaround when Joe Papa took over as chief executive officer,but it seems that littlehas gone his way, especially after the company reported earnings early this week. Some analysts took this opportunity to reevaluate their stance on the stock. Although this might be a buy for some, the returns look to be getting smaller.

  • [By Paul Ausick]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped about 6.2% Friday, to post a new 52-week low of $12.90 after closing at $13.75 on Thursday. The stock’s 52-week high is $70.43. Volume was about double the daily average of around 15.9 million shares. The company completed the sale of some skincare brands to L’Or茅al.

  • [By Chris Lange]

    Valeant Pharmaceuticals International Inc. (NYSE: VRX) made waves early on Tuesday after the company offered a plethora of announcements. First the company gave an update on its late-stage psoriasis trial. Along with this success, Valeant reported the sale of a couple of its business segments, bringing in a sizable amount of cash.

  • [By Kumar Abhishek] Valeant Pharmaceuticals(NYSE:VRX) stock jumps after the company sold Dendreon for hefty gains.
    Flickr

    Shares of Valeant (NYSE:VRX) jumped more than 14% in pre-market trading yesterday, after the Canadian drug maker announced its long-awaited asset sale plans. The stock later gave away some of its gains after Moody’s released a report stating that the asset sales will not impact its credit rating or outlook, though Valeant’s bond prices jumped by 4.5%. Valeant is a classic example of a shareholder value destroyer. Once the darling of Wall Street, the stock has lost more than 90% of its value since its peak in 2014 and is down by more 80% in the last one year. The stock has dragged portfolios of the likes of Bill Ackman and Prof. Aswath Damodaran. However, the asset saleprovides a ray of hope for Valeant’s shareholders.

  • [By WWW.THESTREET.COM]

    Bond prices were much lower early in the day, with yields up by nearly 10 basis points. But fixed income has rallied back (reducing the drop by half on the day). Valeant Pharmaceuticals (VRX) , more weakness. Large pharma lower, led by Eli Lilly (LLY) . Old tech lags, with International Business Machines (IBM) , Intel (INTC) , Cisco Systems (CSCO) and Microsoft (MSFT) all lower. Media roughed up a bit (CBS (CBS) and Comcast (CMCSA) ). The Ugly
    Gold down another $23 to $1,188 (SPDR Gold Trust ETF (GLD) down $2.25). Urban Outfitters (URBN) down $5. NOTE: There will be no “Takeaways” today!   Happy Thanksgiving. Position: Long GLD small, SDS large, JCP large; short SPY, CSCO, CAT small, IWM, TLT small.

  • [By Wayne Duggan]

    Market laggards that could come under additional window dressing selling pressure include Valeant Pharmaceuticals Intl Inc (NYSE: VRX), Endo International plc – Ordinary Shares (NASDAQ: ENDP) and NewLink Genetics Corp (NASDAQ: NLNK).

Top 10 Stocks To Watch For 2018: CVR Refining, LP(CVRR)

Advisors’ Opinion:

  • [By Tyler Crowe]

    For refiners, though, that spread in price led to very lucrative refining margins. As that spread has narrowed, so too has margins for refiners.

    Refining Margins Q4 2012 Q2 2013
    Valero (NYSE: VLO  ) $12.27 $9.26
    Phillips 66 (NYSE: PSX  ) $13.67 $9.88
    HollyFrontier (NYSE: HFC  ) $24.00 $20.28
    CVR Refining (NYSE: CVRR  ) $28.08 $20.30

    Source: Company Earnings releases

  • [By Robert Rapier]

    CVR Partners’ fertilizer plant is located in Coffeyville, Kansas, adjacent to the refinery owned by CVR Refining (NYSE: CVRR). CVR Energy (NYSE: CVI), majority-owned by Carl Icahn via Icahn Enterprises (NYSE: IEP), is the general partner and owns most of the units for both CVR Partners and CVR Refining.

  • [By Lisa Levin]

    Shares of CVR Refining LP (NYSE: CVRR) were down 11 percent to $10.00. Velocity Midstream Partners and CVR Refining disclosed the execution of agreements related to the construction of a crude oil pipeline from the SCOOP play in Central Oklahoma to CVR's Wynnewood refinery.

Top 10 Stocks To Watch For 2018: Euro/Yen(EJ)

Advisors’ Opinion:

  • [By Belinda Cao]

    E-House China Holdings Ltd. (EJ), a real estate brokerage, gained 9.2 percent to $9.70, extending it advance to a third week. Its American depositary receipts retreated 3.1 percent Sept. 20 from the highest level since May 2011.

Top 10 Stocks To Watch For 2018: Brink's Company (The)(BCO)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    World Wrestling Entertainment (NYSE: WW) received a pair of downgrades after its earnings report came in below estimates.

    Sell-Side's Most Noteworthy Calls
    Baird downgraded Cardinal Health (NYSE: CAH) to Neutral.
    Imperial downgraded Brinks (NYSE: BCO) to In-Line.
    Jefferies upgraded AK Steel (NYSE: AKS) to Buy.
    Craig-Hallum upgraded LendingClub (NYSE: LC) to Buy.
    Deal Talk

    General Electric (NYSE: GE) was said to be in talks to acquire Baker Hughes (NYSE: BHI), according to sources as reported by Dow Jones. A deal could be valued at as much as $30 billion. However, Bloomberg later reported that a GE spokesperson said they're in talks with Baker Hughes regarding possible partnerships, but not an acquisition. Halliburton (NYSE: HAL) had attempted to acquire Baker Hughes in 2014, but the DoJ sued to block the deal valued at $35 billion.

  • [By Lee Jackson]

    Another hedge fund that is also a director at Brink’s Co. (NYSE: BCO) was busy selling stock this past week. Starboard parted with a total of 650,000 shares of the security and protection company at prices that fell between $51.47 and $52.05. The total for the sale was set at $34 million. Shares closed on Friday at $52.00. The consensus price target is $56, and the52-week range is $26.86 to $53.90.

Top 10 Stocks To Watch For 2018: Axsome Therapeutics, Inc.(AXSM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Axsome Therapeutics Inc (NASDAQ: AXSM) shares dropped 18 percent to $3.62. Axsome Therapeutics priced 3.74 million shares at $3.74 per share.

    Shares of Canadian Solar Inc. (NASDAQ: CSIQ) were down around 11 percent to $12.10 after the company posted downbeat quarterly earnings and issued a weak forecast.

  • [By William Romov]

    Currently trading at $4.85, Manhattan-based Axsome Therapeutics Inc. (Nasdaq: AXSM) makes drugs to treat depression, Alzheimer’s disease, and chronic pain.

  • [By Jim Robertson]

    On Tuesday, ourUnder the Radar Moversnewsletter suggested shorting small cap clinical-stage biopharmaceutical stock Axsome Therapeutics (NASDAQ: AXSM):

  • [By Paul Ausick]

    Axsome Therapeutics Inc. (NASDAQ: AXSM) traded down about 43% Tuesday and posted a new 52-week low of $3.20 after closing Monday at $5.55. The 52-week high is $6.45. Volume was about 3.8 million, about 19 times the daily average of around 220,000 shares. The company will stop a “futile” portion of a trial of its treatment for knee osteoarthritis.

Top 10 Stocks To Watch For 2018: Luby's, Inc.(LUB)

Advisors’ Opinion:

  • [By Monica Gerson]

    Luby’s, Inc. (NYSE: LUB) is expected to post earnings for the latest quarter.

    Simulations Plus, Inc. (NASDAQ: SLP) is estimated to post its quarterly earnings at $0.07 per share on revenue of $5.00 million.

Top 10 Stocks To Watch For 2018: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Craig Jones]

    Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.

    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:

    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.

    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.

    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

Top 10 Stocks To Watch For 2018: Oak Valley Bancorp (CA)(OVLY)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, financial shares fell 0.32 percent. Meanwhile, top losers in the sector included Oak Valley Bancorp (NASDAQ: OVLY), down 7 percent, and AmTrust Financial Services Inc (NASDAQ: AFSI) down 5 percent.

Top 10 Stocks To Watch For 2018: Corbus Pharmaceuticals Holdings, Inc.(CRBP)

Advisors’ Opinion:

  • [By Sean Williams]

    This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.

    GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%

    As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!

  • [By Keith Speights]

    Corbus Pharmaceuticals (NASDAQ:CRBP) managed to become one of the top-performing biotech stocks on the market in 2016. Over the last 12 months, Corbus’ share price has soared 550%.

Top 10 Stocks To Watch For 2018: Texas Roadhouse, Inc.(TXRH)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Texas Roadhouse Inc. (NASDAQ: TXRH) was raised to Buy from Neutral at BTIG Research.

    USG Corp. (NYSE: USG) was reiterated as Hold but the price target was raised to $35 from $29 (versus a $34.23 close) at Jefferies.

  • [By Joe Tenebruso]

    Fortunately, well-chosen dividend-growth stocks can help you accomplish both of these goals. And with its powerful wealth-building combination of increasing dividend payouts and share-price appreciation, Texas Roadhouse (NASDAQ:TXRH)is one of the best available in the market today.

  • [By Teresa Rivas]

    Texas Roadhouse(TXRH) tumbled more than 12% on Wednesday as itsfourth-quarter earningsand revenue fell short of expectations.

    Pixabay

    The restaurant chain said it earned 29 cents a share on revenue of $484.7 million. Analysts were expecting earnings per share of 38 cents on revenue of $497.3 million.

    Same-restaurant sales grew 1.2% at company restaurants and 2% at domestic franchises. For the first 55 days of the first quarter, Texas Roadhouse said that same-store sales rose 1.5%.

    The company also raised its dividend 10.5% to 21 cents a share.

    Some analysts urged investors to keep the faith in the stock.Barclay’s JeffreyBernsteinreiterated an Overweight rating and $47 price target on thestock:

    We believe TXRH fundamentals remain best-in-class. That said, the near-term focus remains on directional comps. And not unlike the broader industry, TXRH comps eased significantly to close 2016. Such led to disappointing 4Q16 results from top to bottom. Importantly, while the brand ‘is not immune’ to industry comp headwinds, the relative outperformance to the category was maintained. Looking to 2017, key guidance metrics were reiterated. While questions remain on whether the recent easing of industry comps will persist, we remain comforted by TXRH’s relative outperformance and easing comps as we move through 2017.

    Maxim’s Stephen Andersonreiterated a Buy rating, although he took his price target down $4, to $52:

    In our view, TXRH is not immune to the broader slowdown in Casual Dining, but we believe the company will emerge stronger than peers in the next few quarters.TXRHs disappointing 4Q16 comp of +1.3% (blended) was pulled down by a rare negative comp month in December (-2.1%), marking the first time this occurred in almost four years. Comps were +3% or better in both October and November, and comps so far in 1Q17 are positive despite a stormy start to the quarter in

  • [By Dan Caplinger]

    Steakhouse chain Texas Roadhouse (NASDAQ:TXRH) has had to deal with an extremely difficult business environment for restaurant companies, and investors know all too well how tough times can hurt major players in the industry. Last quarter, Texas Roadhouse disappointed investors with sluggish results, and the company wanted to start 2017 on a better footing.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, Texas Roadhouse (NASDAQ:TXRH) and Garmin (NASDAQ:GRMN)made large moves following their quarterly earnings announcements.